Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aimei Health Technology CoAFJK +0.68%16 EV-to-EBITDA is -81.58 as of Jul. 28, 2026. GuruFocus rates AFJK with a GF Score™ of 16/100. The stock has 1 warning sign investors should review. Among 150 Diversified Financial Services companies, Aimei Health Technology Co ranks worse than 666666% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Aimei Health Technology Co's enterprise value is $39.56 Mil.
Aimei Health Technology Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.49 Mil. Therefore, Aimei Health Technology Co's EV-to-EBITDA for today is -81.58.
The historical rank and industry rank for Aimei Health Technology Co's EV-to-EBITDA or its related term are showing as below:
AFJK'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -81.58 Med: 0 Max: 0
Current: -81.58
AFJK's EV-to-EBITDA is ranked worse than 100% of 150
companies
in the Diversified Financial Services industry
Industry Median: 4.425
vs AFJK: -81.58
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Aimei Health Technology Co (NAS:AFJK) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Aimei Health Technology Co's PE Ratio (TTM) for today is calculated as:
Aimei Health Technology Co's share price for today is $11.84.
Aimei Health Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.160.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AFJK vs BRRN, RDAC, MSSAF: EV-to-EBITDA Comparison
For the Shell Companies subindustry, Aimei Health Technology Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aimei Health Technology Co EV-to-EBITDA vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Aimei Health Technology Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Aimei Health Technology Co's EV-to-EBITDA falls into.
Aimei Health Technology Co's current Enterprise Value is $39.56 Mil.
Aimei Health Technology Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.49 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aimei Health Technology Co (AFJK) has a EV-to-EBITDA of -81.58 as of Jul. 28, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Aimei Health Technology Co. According to the industry distribution chart, Aimei Health Technology Co ranks #999999 out of 150 companies in the Diversified Financial Services industry.
Is Aimei Health Technology Co's EV-to-EBITDA too high?
Aimei Health Technology Co's current EV-to-EBITDA is -81.58. Based on the distribution chart, Aimei Health Technology Co ranks #999999 out of 150 companies in the Diversified Financial Services industry, which is in the bottom quartile relative to peers. Overall, Aimei Health Technology Co has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Aimei Health Technology Co's EV-to-EBITDA compare to BRRN and RDAC?
According to the Diversified Financial Services industry distribution chart, Aimei Health Technology Co ranks #999999 out of 150 companies for EV-to-EBITDA. This places Aimei Health Technology Co in the lower half of its industry. The industry median EV-to-EBITDA is 4.43. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Diversified Financial Services company?
The median EV-to-EBITDA among Diversified Financial Services companies is 4.43, based on 150 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Aimei Health Technology Co. For the Diversified Financial Services industry, the median EV-to-EBITDA is 4.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aimei Health Technology Co's current EV-to-EBITDA is -81.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aimei Health Technology Co stock overvalued right now?
Aimei Health Technology Co (AFJK) has a current EV-to-EBITDA of -81.58. The current EV-to-EBITDA is -81.58. Aimei Health Technology Co's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Aimei Health Technology Co (AFJK), the current EV-to-EBITDA is -81.58 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AFJK has been successfully added to your 
